MedTrace Logo

Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen

NCT03811184 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-08-15

No results posted yet for this study

Summary

The clinical evaluation of a patient with a cognitive complaint requires neuropsychological tests, evaluating the integrity of memory and other cognitive functions.

The initial evaluation is made most often by a doctor (general practitioner). In case of need for further examination, a neuropsychological report is made in consultation memory by a neuropsychologist, with further cognitive tests.

The Cognitive Neurology Center at Lariboisière Hospital - Fernand Widal has developed a tool on a digital tablet or smartphone to evaluate cognitive functions: MemScreen.

The purpose of this study is to validate this new neuropsychological test on tablet compared to the neuropsychological reference tests.

Conditions

Interventions

DIAGNOSTIC_TEST

MemScreen

Neuropsychological test on smartphone or digital tablet, on self assesment.

Sponsors & Collaborators

  • MemScreen

    lead INDUSTRY

Principal Investigators

  • Julien Dumurgier, MD · Cognitive Neurology Center of Lariboisiere Hospital

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-17
Primary Completion
2020-03-31
Completion
2020-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03811184 on ClinicalTrials.gov